Angiotensin-converting enzyme 2 is a newly recognized ACE homolog within the renin-angiotensin system (RAS) that is produced and secreted by a variety of cell types. Although ACE2 may act on several substrates, it exhibits high catalytic efficiency, specifically for the hydrolysis of angiotensin (Ang) II to the vasodilator and growth inhibitor heptapeptide. Innovations are new idea, device or process.
Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that breaks into the market or society.
Scientific Tracks Abstracts: Clinical & Experimental Cardiology
Accepted Abstracts: Journal of Clinical and Cellular Immunology